Chuanfan Zhong
Guangzhou, 510200, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A novel biomarker SNHG11 promotes tumor progression and oxidative phosphorylation in clear cell renal cell carcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: August 04, 2026
The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player.
Journal: Translational oncology
Published: May 25, 2026
Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.
Journal: Acta biochimica et biophysica Sinica
Published: January 13, 2026
Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers.
Journal: Nucleic acids research
Published: June 26, 2025
S12micro: a machine learning-derived serum miRNA panel for high-performance pan-cancer diagnosis via liquid biopsy.
Journal: International journal of surgery (London, England)
Published: June 19, 2025
Integrated multi-omics and experimental approaches identify fascin actin-bundling protein 1 as an unfavorable prognostic biomarker in adrenocortical carcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: May 19, 2025
NME4: A novel metabolic-associated biomarker for prognosis prediction and immunotherapy response evaluation in clear cell renal cell carcinoma.
Journal: Molecular immunology
Published: April 16, 2025
Cell division cycle 20 promotes tumor progression and predicts poor clinical outcome in childhood and adult adrenocortical carcinoma.
Journal: Journal of clinical & translational endocrinology
Published: March 27, 2025
Exosome-transmitted long noncoding RNA SNHG1 promotes prostate cancer bone metastasis via YBX1/MMP16 axis.
Journal: Cell death discovery
Published: February 20, 2025
Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma.
Journal: Annals of medicine
Published: December 03, 2024
GG-NER's role in androgen receptor signaling inhibitor response for advanced prostate cancer.
Journal: Cell communication and signaling : CCS
Published: September 05, 2024
Last Updated: 09/26/2026